BCL9/BCL9L in hepatocellular carcinoma: will it or Wnt it be the next therapeutic target?

被引：1
|
作者：
Moghe, Akshata [1 ,2 ]
Monga, Satdarshan P. [1 ,2 ,3 ]
机构：
[1] Univ Pittsburgh, Sch Med, Dept Med, Div Gastroenterol Hepatol & Nutr, Pittsburgh, PA 15213 USA
[2] Univ Pittsburgh, Sch Med, Med Ctr, Pittsburgh Liver Res Ctr, 200 Lothrop St,S-422 BST, Pittsburgh, PA 15261 USA
[3] Univ Pittsburgh, Sch Med, Dept Pathol, Div Expt Pathol, Pittsburgh, PA 15260 USA
来源：
HEPATOLOGY INTERNATIONAL | 2020年 / 14卷 / 04期
关键词：
EXPRESSION; BCL9;
D O I：
10.1007/s12072-020-10059-5
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
引用
收藏
页码：460 / 462
页数：3
相关论文
共 50 条
  • [21] Constitutive scaffolding of multiple Wnt enhanceosome components by Legless/BCL9
    van Tienen, Laurens M.
    Mieszczanek, Juliusz
    Fielder, Marc
    Rutherford, Trevor J.
    Bienz, Mariann
    [J]. ELIFE, 2017, 6
  • [22] Development and utilization of high throughput BCL9/\#946;-catenin binding assays and stabilized \#945;-helical BCL9 peptides to target the BCL9/\#946;-catenin protein-protein interaction as a potential anticancer strategy
    Kawamoto, Steven
    Thompson, Andrea
    Coleska, Adriana
    Wang, Shaomeng
    [J]. CANCER RESEARCH, 2009, 69
  • [23] The Wnt-dependent and Wnt-independent functions of BCL9 in development, tumorigenesis, and immunity: Implications in therapeutic opportunities
    Wu, Minjie
    Dong, Heng
    Xu, Chao
    Sun, Mengqing
    Gao, Haojin
    Bu, Fangtian
    Chen, Jianxiang
    [J]. GENES & DISEASES, 2024, 11 (02) : 701 - 710
  • [24] Matrix stiffness promotes glioma cell stemness by activating BCL9L/Wnt/β-catenin signaling
    Tao, Bei
    Song, Yi
    Wu, Yao
    Yang, Xiaobo
    Peng, Tangming
    Peng, Lilei
    Xia, Kaiguo
    Xia, Xiangguo
    Chen, Ligang
    Zhong, Chuanhong
    [J]. AGING-US, 2021, 13 (04): : 5284 - 5296
  • [25] Design of Triazole-Stapled BCL9 α-Helical Peptides to Target the β-Catenin/B-Cell CLL/lymphoma 9 (BCL9) Protein-Protein Interaction
    Kawamoto, Steven A.
    Coleska, Adriana
    Ran, Xu
    Yi, Han
    Yang, Chao-Yie
    Wang, Shaomeng
    [J]. JOURNAL OF MEDICINAL CHEMISTRY, 2012, 55 (03) : 1137 - 1146
  • [26] Targeted Disruption of the BCL9/β-Catenin Complex Inhibits Oncogenic Wnt Signaling
    Takada, Kohichi
    Zhu, Di
    Bird, Gregory H.
    Sukhdeo, Kumar
    Zhao, Jian-Jun
    Mani, Mala
    Lemieux, Madeleine
    Carrasco, Daniel E.
    Ryan, Jeremy
    Horst, David
    Fulciniti, Mariateresa
    Munshi, Nikhil C.
    Xu, Wenqing
    Kung, Andrew L.
    Shivdasani, Ramesh A.
    Walensky, Loren D.
    Carrasco, Daniel Ruben
    [J]. SCIENCE TRANSLATIONAL MEDICINE, 2012, 4 (148)
  • [27] BCL9 Upregulation in Adrenocortical Carcinoma: A Novel Wnt/β-Catenin Activating Event Driving Adrenocortical Malignancy
    Brown, Taylor C.
    Nicolson, Norman G.
    Korah, Reju
    Carling, Tobias
    [J]. JOURNAL OF THE AMERICAN COLLEGE OF SURGEONS, 2018, 226 (06) : 988 - 995
  • [28] BCL9L DYSFUNCTION PROMOTES ANEUPLOIDY TOLERANCE IN COLON TUMORS
    不详
    [J]. CANCER DISCOVERY, 2017, 7 (03) : 245 - 245
  • [29] Author Correction: Loss of BCL9/9l suppresses Wnt driven tumourigenesis in models that recapitulate human cancer
    David M. Gay
    Rachel A. Ridgway
    Miryam Müller
    Michael C. Hodder
    Ann Hedley
    William Clark
    Joshua D. Leach
    Rene Jackstadt
    Colin Nixon
    David J. Huels
    Andrew D. Campbell
    Thomas G. Bird
    Owen J. Sansom
    [J]. Nature Communications, 10
  • [30] Use of triazole-stapled BCL9/B9L a-helical peptides to target b-catenin and inhibit Wnt signaling
    Kawamoto, Steven A.
    Coleska, Adriana
    Ran, Xu
    Yi, Han
    Yang, Chao-Yie
    Wang, Shaomeng
    [J]. ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2010, 240
12345